Cargando…
A review of liver fibrosis and cirrhosis regression
Cirrhosis has traditionally been considered an irreversible process of end-stage liver disease. With new treatments for chronic liver disease, there is regression of fibrosis and cirrhosis, improvement in clinical parameters (i.e. liver function and hemodynamic markers, hepatic venous pressure gradi...
Autor principal: | Lee, Michael J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Pathologists and the Korean Society for Cytopathology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369136/ https://www.ncbi.nlm.nih.gov/pubmed/37461143 http://dx.doi.org/10.4132/jptm.2023.05.24 |
Ejemplares similares
-
Histopathological evaluation of liver fibrosis and cirrhosis regression
por: Lo, Regina C., et al.
Publicado: (2017) -
Regression of Hepatic Fibrosis and Evolution of Cirrhosis: A Concise Review
por: Khan, Shahbaz, et al.
Publicado: (2021) -
Genomics and proteomics in liver fibrosis and cirrhosis
por: Hannivoort, Rebekka A, et al.
Publicado: (2012) -
Regression of Fibrosis and Reversal of Cirrhosis in Rats by Galectin Inhibitors in Thioacetamide-Induced Liver Disease
por: Traber, Peter G., et al.
Publicado: (2013) -
Efficacy and Safety of Emricasan in Liver Cirrhosis and/or Fibrosis
por: Mu, Li-ya, et al.
Publicado: (2021)